162 related articles for article (PubMed ID: 23378772)
61. Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells.
Koido S; Homma S; Kan S; Takakura K; Namiki Y; Kobayashi H; Ito Z; Uchiyama K; Kajihara M; Arihiro S; Arakawa H; Okamoto M; Ohkusa T; Gong J; Tajiri H
Int J Oncol; 2014 Jul; 45(1):470-8. PubMed ID: 24819411
[TBL] [Abstract][Full Text] [Related]
62. Dendritic cells pulsed with generated tumor cell lysate from Phyllanthus amarus Schum. & Thonn. induces anti-tumor immune response.
Mohamed SIA; Jantan I; Nafiah MA; Seyed MA; Chan KM
BMC Complement Altern Med; 2018 Aug; 18(1):232. PubMed ID: 30081891
[TBL] [Abstract][Full Text] [Related]
63. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
Yin XY; Wang L; Lu MD; Li BJ; Huang JF
Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
[TBL] [Abstract][Full Text] [Related]
64. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
[TBL] [Abstract][Full Text] [Related]
65. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z
Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878
[TBL] [Abstract][Full Text] [Related]
66. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
67. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.
Yang W; Feng J; Chang X; Fu T; Ye X; Zhang H; Li X; Wen H; Feng L; Tong C; Cui H
Gynecol Oncol; 2007 Apr; 105(1):238-43. PubMed ID: 17383546
[TBL] [Abstract][Full Text] [Related]
68. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
69. Characterization of the response of dendritic cells and regulatory T cells to tumor antigens in patients with renal cell carcinoma.
Hou MM; Chang JW; Pang ST; Chiang YJ; Shen YC; Liao SK; Hsieh JJ; Yeh KY; Chang NJ; Chuang CK
Chang Gung Med J; 2010; 33(1):25-35. PubMed ID: 20184792
[TBL] [Abstract][Full Text] [Related]
70. Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.
Kulhankova K; Rouse T; Nasr ME; Field EH
PLoS One; 2012; 7(9):e43609. PubMed ID: 22984435
[TBL] [Abstract][Full Text] [Related]
71. [Antitumor efficacy of fusion cells from esophageal carcinoma cells and dendritic cells as a vaccine in vitro].
Deng YJ; Xia JC; Zhou J; Wang QJ; Zhang PY; Zhang LJ; Rong TH
Ai Zheng; 2007 Feb; 26(2):137-41. PubMed ID: 17298741
[TBL] [Abstract][Full Text] [Related]
72. Probiotic Bio-Three induces Th1 and anti-inflammatory effects in PBMC and dendritic cells.
Hua MC; Lin TY; Lai MW; Kong MS; Chang HJ; Chen CC
World J Gastroenterol; 2010 Jul; 16(28):3529-40. PubMed ID: 20653061
[TBL] [Abstract][Full Text] [Related]
73. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
74. Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.
Parkhurst MR; DePan C; Riley JP; Rosenberg SA; Shu S
J Immunol; 2003 May; 170(10):5317-25. PubMed ID: 12734382
[TBL] [Abstract][Full Text] [Related]
75. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.
Wada J; Yamasaki A; Nagai S; Yanai K; Fuchino K; Kameda C; Tanaka H; Koga K; Nakashima H; Nakamura M; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2008; 28(4C):2401-8. PubMed ID: 18751426
[TBL] [Abstract][Full Text] [Related]
76. Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma.
Schmidt J; Eisold S; Büchler MW; Märten A
Cancer Immunol Immunother; 2004 Nov; 53(11):1018-26. PubMed ID: 15185013
[TBL] [Abstract][Full Text] [Related]
77. [In vitro anti-tumor effect of human dendritic cells vaccine induced by astragalus polysacharin: an experimental study].
Jing XN; Qiu B; Wang JF; Wu YG; Wu JB; Chen DD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1103-7. PubMed ID: 25335335
[TBL] [Abstract][Full Text] [Related]
78. Human Amniotic Membrane-Derived Mesenchymal and Epithelial Cells Exert Different Effects on Monocyte-Derived Dendritic Cell Differentiation and Function.
Magatti M; Caruso M; De Munari S; Vertua E; De D; Manuelpillai U; Parolini O
Cell Transplant; 2015; 24(9):1733-52. PubMed ID: 25259480
[TBL] [Abstract][Full Text] [Related]
79. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
80. Anti-tumoral capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells.
Erhardt M; Schmidt-Wolf IG; Sievers E; Frank S; Strehl J; von Lilienfeld-Toal M; Gorschlüter M
Arch Immunol Ther Exp (Warsz); 2006; 54(6):403-9. PubMed ID: 17122879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
